Q-Line Biotech Limited (NSE:QLINE)

Q-Line Biotech Revenue

In the fiscal year ending March 31, 2026, Q-Line Biotech had annual revenue of 3.47B INR with 10.73% growth. Q-Line Biotech had revenue of 1.15B in the quarter ending March 31, 2026.

• Revenue: 3.47B
• Revenue Growth: +10.73%
• P/S Ratio: 3.78
• Revenue / Employee: 11.10M
• Employees: 313
• Market Cap: 13.12B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	3.47B	336.59M	10.73%
Mar 31, 2025	3.14B	1.10B	54.08%
Mar 31, 2024	2.04B	209.10M	11.44%
Mar 31, 2023	1.83B	-1.21B	-39.92%
Mar 31, 2022	3.04B	1.33B	77.46%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 20, 2026

Data Sources Report a data error